Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Fuji Pharma

Market Cap: JP¥31.1b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Daewon Pharmaceutical

Market Cap: ₩296.0b

A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.

Beijing Biostar Pharmaceuticals

Market Cap: HK$1.6b

A synthetic biology-driven biopharmaceutical company, engages in the research and development, production, and commercialization of oncology products in the People’s Republic of China.

Canopy Growth

Market Cap: CA$287.9m

Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

Innate Pharma

Market Cap: €185.2m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

Santhera Pharmaceuticals Holding

Market Cap: CHF 172.7m

A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.

Quanterix

Market Cap: US$204.7m

A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

Cidara Therapeutics

Market Cap: US$204.1m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Codexis

Market Cap: US$203.8m

Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €182.1m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Actuate Therapeutics

Market Cap: US$202.2m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.

Tevogen Bio Holdings

Market Cap: US$200.4m

A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

Tenax Therapeutics

Market Cap: US$199.7m

A clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.

Design Therapeutics

Market Cap: US$198.7m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

Kodiak Sciences

Market Cap: US$198.5m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Bioventix

Market Cap: UK£148.9m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

biote

Market Cap: US$196.1m

Operates in practice-building business within the hormone optimization space.

Ocugen

Market Cap: US$195.7m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

High Tide

Market Cap: CA$271.1m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Newron Pharmaceuticals

Market Cap: CHF 163.7m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

4basebio

Market Cap: UK£144.1m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.

MediWound

Market Cap: US$189.4m

A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.

Vicore Pharma Holding

Market Cap: SEK 1.8b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

CARGO Therapeutics

Market Cap: US$185.4m

A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

Humacyte

Market Cap: US$184.6m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

AVITA Medical

Market Cap: US$184.2m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Spectral Medical

Market Cap: CA$250.9m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

Cardiff Oncology

Market Cap: US$177.0m

A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.

Hansa Biopharma

Market Cap: SEK 1.7b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

OmniAb

Market Cap: US$176.2m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Y-mAbs Therapeutics

Market Cap: US$175.9m

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.

Annexon

Market Cap: US$175.5m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

Voyager Therapeutics

Market Cap: US$175.4m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

Silence Therapeutics

Market Cap: US$174.7m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

TuHURA Biosciences

Market Cap: US$174.3m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Perspective Therapeutics

Market Cap: US$174.0m

Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.